Lionel Martellet

Conducting vaccine clinical trials in sub-Saharan Africa: operational challenges and lessons learned from the Meningitis Vaccine Project.

E. Marchetti, M. Préziosi, P. Kulkarni, 2012, Vaccine.

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine

R. Adegbola, S. Juvekar, E. Marchetti, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.

K. Neuzil, Wilbur H. Chen, R. Borrow, 2018, The Lancet. Infectious diseases.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years

R. Adegbola, Yuxiao Tang, B. Plikaytis, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons

E. Marchetti, M. Préziosi, F. Laforce, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

D. Diop, R. Adegbola, Yuxiao Tang, 2011, The New England journal of medicine.

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age

R. Adegbola, Yuxiao Tang, B. Plikaytis, 2015, Clinical Infectious Diseases.

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.

Yuxiao Tang, R. Borrow, F. Laforce, 2021, The New England journal of medicine.

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.

Yuxiao Tang, B. Plikaytis, S. Juvekar, 2012, Vaccine.

Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia

S. Lamola, Evangelos Simeonidis, Pankaj Sharma, 2023, The New England journal of medicine.